As at 12 July 2017, we had recommended 24 different ASX and Global stocks in our Trident Confidential Growth Portfolio. Below is a list of the unrealised profits as at 12 July 2017.

Many of the stocks shown below are still current recommendations in some of our reports as we believe that they still have substantial potential over coming years.

Past performance is not a reliable indicator of future performance and you should also ensure that these investments are suitable for your needs and risk profile.


Current and Recent Recommendations

Company

Financial

Date Purchased

July-17    

  Return

    1.28%

Health Insurer

Dec-16

18.15%

 

Medical Technology

Nov-16

32.93%

 



Chipmaker

Technology Company

Sep-16

Aug-16

33.35%

151.22%

 

Social Media Company

Jul-16

37.00%

 

Biotechnology Company

Apr-16

25.53%

 

Biotechnology Company

Mar-16

20.97%

 

Diversified Entertainment Company

Mar-16

7.05%

 

Financial

Feb-16

54.32%

 

Technology

Feb-16

111.38%

 

Bank

Feb-16

40.11%

 

Industrial

Feb-16

30.85%

 

Chip Maker

Feb-16

16.52%

 

European Small Cap

Feb-16

33.12%

 

Financial Services

Jan-16

47.93%

 

Industrial

Jan-16

27.71%

 

Technology Hardware

Jan-16

53.93%

 

Technology

Aug-15

115.08%

 

Financial Services

Jan-15

103.15%

 

Financial Services

Apr-14

91.32%

 

Hospital Operator

Jan-13

169.24%

 

Internet

Oct-11

236.83%

 

Internet

Oct-11

229.95%

 




Open positions average return as at 12 July 2017

 

67.46%